Product Name
ADAMTSL2, Polyclonal Antibody
Full Product Name
ADAMTSL2 Polyclonal Antibody
Product Synonym Names
GPHYSD1
Product Gene Name
anti-ADAMTSL2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Species Reactivity
Human, Mouse, Rat
Purity/Purification
Antigen affinity purification
Concentration
0.7mg/mL (lot specific)
Immunogen
Recombinant protein of human ADAMTSL2
Calculated Molecular Weight: 105kDa
Buffer
PBS with 0.05% sodium azide, 50% glycerol, pH7.3
Preparation and Storage
Store at -20 degree C (regular) and -80 degree C (long term). Avoid freeze / thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of anti-ADAMTSL2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-ADAMTSL2 antibody
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia.
Applications Tested/Suitable for anti-ADAMTSL2 antibody
ELISA (EIA), Western Blot (WB)
Application Notes for anti-ADAMTSL2 antibody
WB: 1:200-1:1000
Western Blot (WB) of anti-ADAMTSL2 antibody
Western Blot analysis of K562 and Jurkat cell using ADAMTSL2 Polyclonal Antibody at dilution of 1:350

NCBI/Uniprot data below describe general gene information for ADAMTSL2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001138792.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001145320.1
[Other Products]
UniProt Secondary Accession #
O60345; B1B0D5[Other Products]
UniProt Related Accession #
Q86TH1[Other Products]
Molecular Weight
104,621 Da
NCBI Official Full Name
ADAMTS-like protein 2
NCBI Official Synonym Full Names
ADAMTS-like 2
NCBI Official Symbol
ADAMTSL2??[Similar Products]
NCBI Official Synonym Symbols
GPHYSD1
??[Similar Products]
NCBI Protein Information
ADAMTS-like protein 2; ADAMTSL-2
UniProt Protein Name
ADAMTS-like protein 2
Protein Family
ADAMTS-like protein
UniProt Gene Name
ADAMTSL2??[Similar Products]
UniProt Synonym Gene Names
KIAA0605; ADAMTSL-2??[Similar Products]
UniProt Entry Name
ATL2_HUMAN
NCBI Summary for ADAMTSL2
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia. [provided by RefSeq, Feb 2009]
UniProt Comments for ADAMTSL2
ADAMTSL2: Defects in ADAMTSL2 are the cause of geleophysic dysplasia type 1 (GPHYSD1). An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues.
Protein type: Secreted; Protease; Extracellular matrix; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 9q34.2
Cellular Component: proteinaceous extracellular matrix
Molecular Function: protein binding; zinc ion binding; metalloendopeptidase activity
Biological Process: proteolysis; negative regulation of transforming growth factor beta receptor signaling pathway
Disease: Geleophysic Dysplasia 1
Research Articles on ADAMTSL2
1. Two novel homozygous missense mutations in the ADAMTSL2 gene underlie geleophysic dysplasia in two consanguineous families from the United Arab Emirates.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.